BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15932373)

  • 1. Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project.
    Van Cauwenberge P; Watelet JB; Van Zele T; Bousquet J; Burney P; Zuberbier T;
    Allergy; 2005 Jul; 60(7):858-64. PubMed ID: 15932373
    [No Abstract]   [Full Text] [Related]  

  • 2. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
    Bousquet J; Burney PG; Zuberbier T; Cauwenberge PV; Akdis CA; Bindslev-Jensen C; Bonini S; Fokkens WJ; Kauffmann F; Kowalski ML; Lodrup-Carlsen K; Mullol J; Nizankowska-Mogilnicka E; Papadopoulos N; Toskala E; Wickman M; Anto J; Auvergne N; Bachert C; Bousquet PJ; Brunekreef B; Canonica GW; Carlsen KH; Gjomarkaj M; Haahtela T; Howarth P; Lenzen G; Lotvall J; Radon K; Ring J; Salapatas M; Schünemann HJ; Szczecklik A; Todo-Bom A; Valovirta E; von Mutius E; Zock JP
    Allergy; 2009 Jul; 64(7):969-77. PubMed ID: 19392994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases].
    Gjomarkaj M; Pace E; Canonica GW; Bonini S; Ricci G; Burney P; Zuberbier T; Van Cauwenberge P; Bousquet J
    Minerva Med; 2009 Dec; 100(6):525-34. PubMed ID: 20010485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Global Allergy and Asthma European Network (GA2LEN) addresses the epidemic of allergy and asthma].
    Panzer PC; van Cauvenberg P; Bousquet J
    Cas Lek Cesk; 2010; 149(1):32-7. PubMed ID: 20662458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a standardized quality management system for the European Health Network GA2LEN.
    Heinzerling L; Burbach G; van Cauwenberge P; Papageorgiou P; Carlsen KH; Lødrup Carlsen KC; Zuberbier T
    Allergy; 2010 Jun; 65(6):743-52. PubMed ID: 19886923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Allergy and Asthma European Network (GA2LEN)--a focus for paediatric allergy research.
    Warner JO
    Pediatr Allergy Immunol; 2006 May; 17(3):163. PubMed ID: 16672001
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project.
    Bousquet PJ; Demoly P; Romano A; Aberer W; Bircher A; Blanca M; Brockow K; Pichler W; Torres MJ; Terreehorst I; Arnoux B; Atanaskovic-Markovic M; Barbaud A; Bijl A; Bonadonna P; Burney PG; Caimmi S; Canonica GW; Cernadas J; Dahlen B; Daures JP; Fernandez J; Gomes E; Gueant JL; Kowalski ML; Kvedariene V; Mertes PM; Martins P; Nizankowska-Mogilnicka E; Papadopoulos N; Ponvert C; Pirmohamed M; Ring J; Salapatas M; Sanz ML; Szczeklik A; Van Ganse E; De Weck AL; Zuberbier T; Merk HF; Sachs B; Sidoroff A;
    Allergy; 2009 Feb; 64(2):194-203. PubMed ID: 19178398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GA2LEN (Global Allergy and Asthma European Network)].
    Bousquet J; Kauffmann F; Demoly P; Leynaert B; Bousquet PJ; Demenais F; Lenzen G; Burney PG; Zuberbier T; Van Cauwenberge P
    Rev Mal Respir; 2009 Jun; 26(6):577-86. PubMed ID: 19623103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs -- a GALEN initiative.
    Keil T; Kulig M; Simpson A; Custovic A; Wickman M; Kull I; Lødrup Carlsen KC; Carlsen KH; Smit HA; Wijga AH; Schmid S; Berg A; Bollrath C; Eller E; Bindslev-Jensen C; Halken S; Høst A; Heinrich J; Porta D; Forastiere F; Brunekreef B; Krämer U; Willich SN; Wahn U; Lau S;
    Allergy; 2006 Feb; 61(2):221-8. PubMed ID: 16409200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GA2LEN--The Global Allergy and Asthma European Network.
    Frew AJ
    Clin Exp Allergy; 2005 Feb; 35(2):122-5. PubMed ID: 15725181
    [No Abstract]   [Full Text] [Related]  

  • 11. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures--a GA2LEN initiative.
    Keil T; Kulig M; Simpson A; Custovic A; Wickman M; Kull I; Lødrup Carlsen KC; Carlsen KH; Smit HA; Wijga AH; Schmid S; Von Berg A; Bollrath C; Eller E; Bindslev-Jensen C; Halken S; Høst A; Heinrich J; Fantini MP; Brunekreef B; Krämer U; Willich SN; Wahn U; Lau S;
    Allergy; 2006 Sep; 61(9):1104-11. PubMed ID: 16918514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network.
    Heinzerling L; Frew AJ; Bindslev-Jensen C; Bonini S; Bousquet J; Bresciani M; Carlsen KH; van Cauwenberge P; Darsow U; Fokkens WJ; Haahtela T; van Hoecke H; Jessberger B; Kowalski ML; Kopp T; Lahoz CN; Lodrup Carlsen KC; Papadopoulos NG; Ring J; Schmid-Grendelmeier P; Vignola AM; Wöhrl S; Zuberbier T
    Allergy; 2005 Oct; 60(10):1287-300. PubMed ID: 16134996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.
    Zuberbier T; Aberer W; Asero R; Bindslev-Jensen C; Brzoza Z; Canonica GW; Church MK; Ensina LF; Giménez-Arnau A; Godse K; Gonçalo M; Grattan C; Hebert J; Hide M; Kaplan A; Kapp A; Abdul Latiff AH; Mathelier-Fusade P; Metz M; Saini SS; Sánchez-Borges M; Schmid-Grendelmeier P; Simons FE; Staubach P; Sussman G; Toubi E; Vena GA; Wedi B; Zhu XJ; Nast A; Maurer M; ; ; ;
    Allergy; 2014 Jul; 69(7):e1-29. PubMed ID: 24898678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology.
    Lötvall J; Pawankar R; Wallace DV; Akdis CA; Rosenwasser LJ; Weber RW; Wesley Burks A; Casale TB; Lockey RF; Papadopoulos NG; Fineman SM; Ledford DK;
    Allergy; 2012 Apr; 67(4):449-50. PubMed ID: 22414196
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA2LEN initiative.
    Eller E; Roll S; Chen CM; Herbarth O; Wichmann HE; von Berg A; Krämer U; Mommers M; Thijs C; Wijga A; Brunekreef B; Fantini MP; Bravi F; Forastiere F; Porta D; Sunyer J; Torrent M; Høst A; Halken S; Lødrup Carlsen KC; Carlsen KH; Wickman M; Kull I; Wahn U; Willich SN; Lau S; Keil T; Heinrich J;
    Allergy; 2008 Nov; 63(11):1491-8. PubMed ID: 18721248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].
    Wöhrl S; Radon K; Ring J; Moritz K; Akdis C; Burney P; Van Cauwenberge P; Bousquet J; Zuberbier T
    Wien Klin Wochenschr; 2009; 121(17-18):589-97. PubMed ID: 19890749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence.
    Maurer M; Metz M; Bindslev-Jensen C; Bousquet J; Canonica GW; Church MK; Godse KV; Grattan CE; Hide M; Kocatürk E; Magerl M; Makris M; Meshkova R; Saini SS; Sussman G; Toubi E; Zhao Z; Zuberbier T; Gimenez-Arnau A
    Allergy; 2016 Aug; 71(8):1210-8. PubMed ID: 27038243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards European cooperation in the professional regulation of nursing].
    Debout C
    Soins; 2006 Oct; (709):49-52. PubMed ID: 17111870
    [No Abstract]   [Full Text] [Related]  

  • 19. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper.
    Bousquet J; Anto J; Sunyer J; Nieuwenhuijsen M; Vrijheid M; Keil T; ; ; ;
    Int Arch Allergy Immunol; 2013; 161(1):1-10. PubMed ID: 23258290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important questions in allergy: novel research areas.
    Bousquet J; Bieber T; Fokkens W; Kowalski ML; Humbert M; Niggemann B; Simon HU; Burney P; van Cauwenberge P; Zuberbier T; Akdis CA; Demoly P
    Allergy; 2008 Feb; 63(2):143-7. PubMed ID: 18186804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.